Efficacy Type 2 Diabetes SURPASS-2 Trial A direct comparison between tirzepatide and semaglutide in the SURPASS-2 trial demonstrated: HbA1c reduction : Tirzepatide (15 mg): up to 2.3% Semaglutide (1 mg): 1.9% Average weight loss : Tirzepatide: 5.5 kg Semaglutide: 3.8 kg Meta-Analysis Findings A meta-analysis of multiple trials confirmed tirzepatides superiority: 5 mg dose : 1.5 higher odds of achieving 5% weight loss than semaglutide 10 mg dose : 3.0 higher odds 15 mg dose : 4.2 higher odds However, higher tirzepatide doses also led to slightly higher discontinuation rates due to gastrointestinal side effects
Arms can generally be treated with one procedure
What the Evidence Shows Why Joint Pain May Occur During Mounjaro Treatment Managing Joint Pain While Taking Mounjaro When to Seek Medical Advice About Joint Pain on Mounjaro Scientific References Frequently Asked Questions Understanding Mounjaro (Tirzepatide) and Its Common Side Effects Mounjaro is the brand name for tirzepatide, a prescription medicine licensed in the United Kingdom for the treatment of type 2 diabetes mellitus in adults
Cui J, Li H, Zhang T, Lin F, Chen M, Zhang G, Feng Z (2025) Research progress on the mechanism of curcumin anti-oxidative stress based on signaling pathway
This enhanced stability contributes to dependable pharmaceutical performance over time